Medical University Innsbruck
Innsbruck, Tyrol, 6020, Austria
NCT Number: NCT05946707
The goal of this randomized clinical trial is to compare a liberal versus restrictive oxygen supply (fraction of inspired oxygen, FiO2) strategy in patients scheduled for thoracic surgery requiring one-lung ventilation during lung isolation. The primary and secondary outcome parameters are:
* oxygenation of the blood after 30 minutes of one-lung ventilation, assessed by PaO2/FiO2 ratio * time to lung collapse after start of one-lung ventilation
Participants in the control goup will receive an oxygen content of 100% before lung isolation, which will be subsequently decreased to achieve normoxia or mild hyperoxia (PaO2 of 75-120 mmHg).
The intervention group will receive the previous, during two-lung ventilation set, oxygen content and after lung isolation oxygen supply will be increased to secure adequate oxygenation of the blood (PaO2 75-120 mmHg) during one-lung ventilation.
The investigators hypothesize, that a higher fraction of inspired oxygen may impede hypoxic pulmonary vasoconstriction of the collapsed lung and thus decrease overall oxygenation performance during one-lung ventilation. Secondary endpoint will be the time to lung collapse, as a lower fraction of inspired oxygen and thus a higher nitrogen content may impede lung collapse.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Innsbruck, Tyrol, 6020, Austria
After anesthesia induction and securing the airway with a double lumen tracheal tube, the patient will be ventilated with pressure-controlled ventilation (PCV) and the following settings during two-lung ventilation (TLV): positive end-expiratory pressure of 5 cmH2O, peak pressure set to achieve a tidal volume of 6-8 ml/kg, respiratory rate set to achieve normocapnia, I:E ratio set to 1:1.5, FiO2 adjusted to achieve normoxia. After changing to lateral position, the patient will be randomized to one of the following group:
During OLV the applied tidal volume will be reduced to 4-6 ml/kg by an appropriate adjustment of peak pressure, otherwise the ventilator settings will not be changed. After 30 minutes of OLV the intervention period ends and because in both groups oxygenation will be adjusted to achieve a PaO2 of 75-120 mmHg during OLV, the routine anesthetic regime of both groups will not differ in the further course of thoracic surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oxygen supply will be limited to guarantee normoxia at the beginning of OLV.
Oxygen supply will be maximized to 100% at the beginning of OLV
Time frame: Primary outcome timepoint is defined at 30 minutes after start of OLV
Oxygenation of the blood will be assessed by the paO2/FiO2 ratio and compared between groups.
Time frame: Lung collapse will be assessed and recorded as no collapse, partial collapse or complete collapse at 10, 20, 30 and 60 minutes after start of one-lung ventilation.
Time to complete lung collapse will be recorded and compared between groups.
Time frame: Follow-up will be completed after end of hospital stay or 30-days of hospital stay.
Occurence of postoperative pulmonary complications will be assessed postoperatively
Medical University Innsbruck
Other
Effects of Oxygen Supply on Hypoxic Pulmonary Vasoconstriction and Lung Collapse After Lung Isolation in Thoracic Surgery - a Prospective, Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04381949
Airway Management, Atelectasis
Rouen, France
View Trial DetailsNCT05875662
Atelectasis, Bronchoscopy
Beijing, Beijing Municipality, China
View Trial DetailsNCT07594379
Atelectasis, Lung Diseases
View Trial DetailsNCT07325812
Atelectasis, General Anesthesia
Istanbul, Turkey (Türkiye)
View Trial Details